One of such potential prognostic markers postulated were changes in telomere length because it was shown that telomere length was shorter in CML cells as compared to age-matched healthy individuals or BCR::ABL1-negative T lymphocytes from the same patients (Brümmendorf et al. 2000). Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.